Table 2 Logistic regression analysis of the significant factors for ACT benefit

Age

0.96

0.94–0.99

< 0.001

0.97

0.94–0.99

0.016

Gender:

 Female

Reference

Reference

 Male

0.58

0.34–0.99

0.04

0.54

0.26–0.95

0.039

Race:

 White

Reference

Reference

 Non-White

1.48

0.87–2.53

0.15

0.96

0.51–1.82

0.911

Marital status:

 Married

Reference

Reference

 Unmarried

0.59

0.34–1.04

0.07

0.42

0.22–0.81

0.009

Grade:

 I/II

Reference

Reference

 III/IV

1.43

0.85–2.4

0.17

1.01

0.55–1.86

0.965

Pathology:

 Non-SRCC

Reference

Reference

 SRCC

1.25

0.64–2.47

0.51

Primary site:

 Cardia

Reference

Reference

 Distal site

2.75

1.43–5.32

< 0.001

2.33

1.07–5.1

0.034

 Middle site

2.28

1.17–4.45

0.02

1.75

0.8–3.84

0.163

 Overlapping/NOS

1.88

0.69–5.11

0.22

1.4

0.46–4.31

0.557

Tumor size:

 ≤ 2 cm

Reference

Reference

 ≤ 5 cm

0.95

0.53–1.69

0.85

0.99

0.52–1.87

0.97

 > 5 cm

1.01

0.45–2.29

0.98

0.88

0.36–2.15

0.772

 Unknown

0.4

0.14–1.11

0.08

0.39

0.13–0.93

0.007

RNE:

 ≥ 16

Reference

Reference

 1–15

0.52

0.31–0.88

0.02

0.47

0.27–0.84

0.01

Stage:

 T1N1M0

Reference

Reference

 T2N0M0

0.96

0.58–1.61

0.89